ES2347320T3 - Hidrolizados proteicos enriquecidos en peptidos que tienen un resto de prolina carboxi terminal. - Google Patents

Hidrolizados proteicos enriquecidos en peptidos que tienen un resto de prolina carboxi terminal. Download PDF

Info

Publication number: ES2347320T3
Authority: ES; Spain
Prior art keywords: proline; protein; peptides; baselineskip; endoprotease
Prior art date: 2000-12-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

ES01985386T

Other languages

English (en)

Spanish (es)

Inventor

Luppo Edens

Van Der Robertus Antonius Mijndert Hoeven

Veronique Delest

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

DSM IP Assets BV

Original Assignee

DSM IP Assets BV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-07

Filing date

2001-12-06

Publication date

2010-10-28

2001-12-06 Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV

2010-10-28 Application granted granted Critical

2010-10-28 Publication of ES2347320T3 publication Critical patent/ES2347320T3/es

2021-12-06 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Chemical compound OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 title claims abstract description 312
108090000765 processed proteins & peptides Proteins 0.000 title claims description 327
102000004196 processed proteins & peptides Human genes 0.000 title claims description 294
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims abstract description 268
101710118538 Protease Proteins 0.000 claims abstract description 236
108090000623 proteins and genes Proteins 0.000 claims abstract description 210
102000004169 proteins and genes Human genes 0.000 claims abstract description 130
238000000034 method Methods 0.000 claims abstract description 111
239000003531 protein hydrolysate Substances 0.000 claims abstract description 69
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 59
239000000203 mixture Substances 0.000 claims abstract description 51
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims abstract description 48
239000000758 substrate Substances 0.000 claims abstract description 46
102000005367 Carboxypeptidases Human genes 0.000 claims abstract description 29
108010006303 Carboxypeptidases Proteins 0.000 claims abstract description 29
235000019658 bitter taste Nutrition 0.000 claims abstract description 27
108090000787 Subtilisin Proteins 0.000 claims abstract description 26
235000013305 food Nutrition 0.000 claims abstract description 24
235000018102 proteins Nutrition 0.000 claims description 129
150000001413 amino acids Chemical class 0.000 claims description 70
241000228245 Aspergillus niger Species 0.000 claims description 63
230000002255 enzymatic effect Effects 0.000 claims description 38
108010046377 Whey Proteins Proteins 0.000 claims description 30
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 28
235000021240 caseins Nutrition 0.000 claims description 28
239000005018 casein Substances 0.000 claims description 27
102000007544 Whey Proteins Human genes 0.000 claims description 26
239000005862 Whey Substances 0.000 claims description 16
OAWXZFGKDDFTGS-BYPYZUCNSA-N (2s)-pyrrolidine-1,2-dicarboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(O)=O OAWXZFGKDDFTGS-BYPYZUCNSA-N 0.000 claims description 10
108010068370 Glutens Proteins 0.000 claims description 10
235000021312 gluten Nutrition 0.000 claims description 10
230000002829 reductive effect Effects 0.000 claims description 10
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
238000000108 ultra-filtration Methods 0.000 claims description 3
235000013361 beverage Nutrition 0.000 claims 1
238000001471 micro-filtration Methods 0.000 claims 1
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
102000004190 Enzymes Human genes 0.000 abstract description 84
108090000790 Enzymes Proteins 0.000 abstract description 84
108010009736 Protein Hydrolysates Proteins 0.000 abstract description 29
108010033276 Peptide Fragments Proteins 0.000 abstract description 10
102000007079 Peptide Fragments Human genes 0.000 abstract description 10
239000000413 hydrolysate Substances 0.000 abstract 1
235000013930 proline Nutrition 0.000 description 285
229920001184 polypeptide Polymers 0.000 description 135
210000004027 cell Anatomy 0.000 description 122
230000000694 effects Effects 0.000 description 84
229940088598 enzyme Drugs 0.000 description 83
235000001014 amino acid Nutrition 0.000 description 75
229940024606 amino acid Drugs 0.000 description 72
239000000523 sample Substances 0.000 description 65
230000014509 gene expression Effects 0.000 description 64
108091033319 polynucleotide Proteins 0.000 description 63
239000002157 polynucleotide Substances 0.000 description 63
102000040430 polynucleotide Human genes 0.000 description 63
239000000047 product Substances 0.000 description 61
108010076119 Caseins Proteins 0.000 description 49
102000011632 Caseins Human genes 0.000 description 49
239000013598 vector Substances 0.000 description 49
108091028043 Nucleic acid sequence Proteins 0.000 description 47
108020004414 DNA Proteins 0.000 description 40
238000004458 analytical method Methods 0.000 description 40
239000013615 primer Substances 0.000 description 40
239000012634 fragment Substances 0.000 description 37
238000004519 manufacturing process Methods 0.000 description 35
125000003729 nucleotide group Chemical group 0.000 description 33
240000004808 Saccharomyces cerevisiae Species 0.000 description 32
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 32
150000007523 nucleic acids Chemical group 0.000 description 32
239000002773 nucleotide Substances 0.000 description 31
238000002360 preparation method Methods 0.000 description 31
239000000243 solution Substances 0.000 description 31
241000228212 Aspergillus Species 0.000 description 30
238000011534 incubation Methods 0.000 description 30
239000000463 material Substances 0.000 description 28
238000003752 polymerase chain reaction Methods 0.000 description 27
230000002538 fungal effect Effects 0.000 description 26
102000035195 Peptidases Human genes 0.000 description 23
108091005804 Peptidases Proteins 0.000 description 23
239000002299 complementary DNA Substances 0.000 description 23
241000196324 Embryophyta Species 0.000 description 22
241000233866 Fungi Species 0.000 description 21
239000004365 Protease Substances 0.000 description 21
241000894007 species Species 0.000 description 21
108010073771 Soybean Proteins Proteins 0.000 description 20
235000010469 Glycine max Nutrition 0.000 description 19
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 18
240000006439 Aspergillus oryzae Species 0.000 description 18
108091026890 Coding region Proteins 0.000 description 18
239000002253 acid Substances 0.000 description 18
238000006243 chemical reaction Methods 0.000 description 18
230000004048 modification Effects 0.000 description 18
238000012986 modification Methods 0.000 description 18
235000021247 β-casein Nutrition 0.000 description 18
238000000855 fermentation Methods 0.000 description 17
230000004151 fermentation Effects 0.000 description 17
239000000843 powder Substances 0.000 description 17
108010076504 Protein Sorting Signals Proteins 0.000 description 16
125000003275 alpha amino acid group Chemical group 0.000 description 16
238000009396 hybridization Methods 0.000 description 16
229940001941 soy protein Drugs 0.000 description 16
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
230000000295 complement effect Effects 0.000 description 15
238000002474 experimental method Methods 0.000 description 15
238000006467 substitution reaction Methods 0.000 description 15
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
239000002609 medium Substances 0.000 description 14
230000001965 increasing effect Effects 0.000 description 13
239000003550 marker Substances 0.000 description 13
235000021119 whey protein Nutrition 0.000 description 13
235000002247 Aspergillus oryzae Nutrition 0.000 description 12
241000588724 Escherichia coli Species 0.000 description 12
230000002378 acidificating effect Effects 0.000 description 12
230000003321 amplification Effects 0.000 description 12
235000010633 broth Nutrition 0.000 description 12
238000005516 engineering process Methods 0.000 description 12
239000013604 expression vector Substances 0.000 description 12
230000007062 hydrolysis Effects 0.000 description 12
238000006460 hydrolysis reaction Methods 0.000 description 12
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 12
238000003199 nucleic acid amplification method Methods 0.000 description 12
102000039446 nucleic acids Human genes 0.000 description 12
108020004707 nucleic acids Proteins 0.000 description 12
239000013612 plasmid Substances 0.000 description 12
108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 11
238000010367 cloning Methods 0.000 description 11
230000029087 digestion Effects 0.000 description 11
230000003241 endoproteolytic effect Effects 0.000 description 11
230000002797 proteolythic effect Effects 0.000 description 11
238000012360 testing method Methods 0.000 description 11
238000007792 addition Methods 0.000 description 10
235000013350 formula milk Nutrition 0.000 description 10
230000002209 hydrophobic effect Effects 0.000 description 10
235000013336 milk Nutrition 0.000 description 10
239000008267 milk Substances 0.000 description 10
210000004080 milk Anatomy 0.000 description 10
230000036961 partial effect Effects 0.000 description 10
238000000746 purification Methods 0.000 description 10
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
241000193830 Bacillus <bacterium> Species 0.000 description 9
241000894006 Bacteria Species 0.000 description 9
102000008186 Collagen Human genes 0.000 description 9
108010035532 Collagen Proteins 0.000 description 9
102000018389 Exopeptidases Human genes 0.000 description 9
108010091443 Exopeptidases Proteins 0.000 description 9
230000001580 bacterial effect Effects 0.000 description 9
229920001436 collagen Polymers 0.000 description 9
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
230000003612 virological effect Effects 0.000 description 9
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 8
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
230000008901 benefit Effects 0.000 description 8
230000002950 deficient Effects 0.000 description 8
238000002703 mutagenesis Methods 0.000 description 8
231100000350 mutagenesis Toxicity 0.000 description 8
230000008569 process Effects 0.000 description 8
230000010076 replication Effects 0.000 description 8
241001370055 Aspergillus niger CBS 513.88 Species 0.000 description 7
241001465754 Metazoa Species 0.000 description 7
102000014171 Milk Proteins Human genes 0.000 description 7
108010011756 Milk Proteins Proteins 0.000 description 7
102000056251 Prolyl Oligopeptidases Human genes 0.000 description 7
101710178372 Prolyl endopeptidase Proteins 0.000 description 7
235000021307 Triticum Nutrition 0.000 description 7
241000209140 Triticum Species 0.000 description 7
125000000539 amino acid group Chemical group 0.000 description 7
239000000872 buffer Substances 0.000 description 7
239000000796 flavoring agent Substances 0.000 description 7
235000019634 flavors Nutrition 0.000 description 7
239000001963 growth medium Substances 0.000 description 7
230000002779 inactivation Effects 0.000 description 7
238000010348 incorporation Methods 0.000 description 7
244000005700 microbiome Species 0.000 description 7
235000016709 nutrition Nutrition 0.000 description 7
230000001105 regulatory effect Effects 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
239000006228 supernatant Substances 0.000 description 7
235000019640 taste Nutrition 0.000 description 7
230000009466 transformation Effects 0.000 description 7
238000011282 treatment Methods 0.000 description 7
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 6
102000007698 Alcohol dehydrogenase Human genes 0.000 description 6
108010021809 Alcohol dehydrogenase Proteins 0.000 description 6
241000351920 Aspergillus nidulans Species 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
239000012901 Milli-Q water Substances 0.000 description 6
238000013459 approach Methods 0.000 description 6
235000013339 cereals Nutrition 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 6
238000003776 cleavage reaction Methods 0.000 description 6
230000008030 elimination Effects 0.000 description 6
238000003379 elimination reaction Methods 0.000 description 6
235000019253 formic acid Nutrition 0.000 description 6
238000010438 heat treatment Methods 0.000 description 6
238000011141 high resolution liquid chromatography Methods 0.000 description 6
238000002955 isolation Methods 0.000 description 6
108020004999 messenger RNA Proteins 0.000 description 6
235000021239 milk protein Nutrition 0.000 description 6
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
239000002987 primer (paints) Substances 0.000 description 6
230000007017 scission Effects 0.000 description 6
230000028327 secretion Effects 0.000 description 6
238000012163 sequencing technique Methods 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
238000000539 two dimensional gel electrophoresis Methods 0.000 description 6
235000013311 vegetables Nutrition 0.000 description 6
108010065511 Amylases Proteins 0.000 description 5
108020004705 Codon Proteins 0.000 description 5
241000589566 Elizabethkingia meningoseptica Species 0.000 description 5
244000068988 Glycine max Species 0.000 description 5
240000005979 Hordeum vulgare Species 0.000 description 5
235000007340 Hordeum vulgare Nutrition 0.000 description 5
241000235649 Kluyveromyces Species 0.000 description 5
108010060630 Lactoglobulins Proteins 0.000 description 5
102000008192 Lactoglobulins Human genes 0.000 description 5
108010006035 Metalloproteases Proteins 0.000 description 5
102000005741 Metalloproteases Human genes 0.000 description 5
240000007594 Oryza sativa Species 0.000 description 5
235000007164 Oryza sativa Nutrition 0.000 description 5
241000235070 Saccharomyces Species 0.000 description 5
238000005903 acid hydrolysis reaction Methods 0.000 description 5
235000013405 beer Nutrition 0.000 description 5
239000012141 concentrate Substances 0.000 description 5
230000003247 decreasing effect Effects 0.000 description 5
229940079919 digestives enzyme preparation Drugs 0.000 description 5
238000001914 filtration Methods 0.000 description 5
239000012467 final product Substances 0.000 description 5
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 5
238000012261 overproduction Methods 0.000 description 5
235000009566 rice Nutrition 0.000 description 5
238000012546 transfer Methods 0.000 description 5
241000701161 unidentified adenovirus Species 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
102000013142 Amylases Human genes 0.000 description 4
241000283690 Bos taurus Species 0.000 description 4
241000701489 Cauliflower mosaic virus Species 0.000 description 4
108090000317 Chymotrypsin Proteins 0.000 description 4
239000003155 DNA primer Substances 0.000 description 4
101150108358 GLAA gene Proteins 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
241000713869 Moloney murine leukemia virus Species 0.000 description 4
108700026244 Open Reading Frames Proteins 0.000 description 4
241000235648 Pichia Species 0.000 description 4
108020004511 Recombinant DNA Proteins 0.000 description 4
241000714474 Rous sarcoma virus Species 0.000 description 4
102000012479 Serine Proteases Human genes 0.000 description 4
108010022999 Serine Proteases Proteins 0.000 description 4
108090001109 Thermolysin Proteins 0.000 description 4
102000004142 Trypsin Human genes 0.000 description 4
108090000631 Trypsin Proteins 0.000 description 4
239000008351 acetate buffer Substances 0.000 description 4
235000019418 amylase Nutrition 0.000 description 4
230000000692 anti-sense effect Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
235000013351 cheese Nutrition 0.000 description 4
229960002376 chymotrypsin Drugs 0.000 description 4
239000013599 cloning vector Substances 0.000 description 4
235000020247 cow milk Nutrition 0.000 description 4
238000012217 deletion Methods 0.000 description 4
230000037430 deletion Effects 0.000 description 4
235000005911 diet Nutrition 0.000 description 4
210000003527 eukaryotic cell Anatomy 0.000 description 4
230000000367 exoproteolytic effect Effects 0.000 description 4
230000006870 function Effects 0.000 description 4
239000000499 gel Substances 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
230000003993 interaction Effects 0.000 description 4
239000007788 liquid Substances 0.000 description 4
210000004962 mammalian cell Anatomy 0.000 description 4
229910052751 metal Inorganic materials 0.000 description 4
239000002184 metal Substances 0.000 description 4
230000000813 microbial effect Effects 0.000 description 4
230000007935 neutral effect Effects 0.000 description 4
235000015097 nutrients Nutrition 0.000 description 4
230000035764 nutrition Effects 0.000 description 4
239000008363 phosphate buffer Substances 0.000 description 4
238000012216 screening Methods 0.000 description 4
238000000926 separation method Methods 0.000 description 4
238000002741 site-directed mutagenesis Methods 0.000 description 4
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
235000019710 soybean protein Nutrition 0.000 description 4
235000011496 sports drink Nutrition 0.000 description 4
210000000130 stem cell Anatomy 0.000 description 4
239000012588 trypsin Substances 0.000 description 4
229960001322 trypsin Drugs 0.000 description 4
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
229920001817 Agar Polymers 0.000 description 3
239000004382 Amylase Substances 0.000 description 3
241000131386 Aspergillus sojae Species 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
102000005593 Endopeptidases Human genes 0.000 description 3
108010059378 Endopeptidases Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
229930010555 Inosine Natural products 0.000 description 3
102000004195 Isomerases Human genes 0.000 description 3
108090000769 Isomerases Proteins 0.000 description 3
241001138401 Kluyveromyces lactis Species 0.000 description 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
241000700605 Viruses Species 0.000 description 3
240000008042 Zea mays Species 0.000 description 3
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
235000002017 Zea mays subsp mays Nutrition 0.000 description 3
239000008272 agar Substances 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
230000033228 biological regulation Effects 0.000 description 3
235000019636 bitter flavor Nutrition 0.000 description 3
239000004202 carbamide Substances 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
238000012512 characterization method Methods 0.000 description 3
239000013611 chromosomal DNA Substances 0.000 description 3
239000013065 commercial product Substances 0.000 description 3
238000001816 cooling Methods 0.000 description 3
235000005822 corn Nutrition 0.000 description 3
230000001186 cumulative effect Effects 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
230000037213 diet Effects 0.000 description 3
235000021245 dietary protein Nutrition 0.000 description 3
238000004090 dissolution Methods 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
238000009826 distribution Methods 0.000 description 3
238000010828 elution Methods 0.000 description 3
239000003623 enhancer Substances 0.000 description 3
238000000605 extraction Methods 0.000 description 3
108010007119 flavourzyme Proteins 0.000 description 3
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
238000002744 homologous recombination Methods 0.000 description 3
230000006801 homologous recombination Effects 0.000 description 3
239000012499 inoculation medium Substances 0.000 description 3
229960003786 inosine Drugs 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000012528 membrane Substances 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 3
230000002018 overexpression Effects 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
238000011084 recovery Methods 0.000 description 3
230000001603 reducing effect Effects 0.000 description 3
230000009467 reduction Effects 0.000 description 3
238000006722 reduction reaction Methods 0.000 description 3
230000003578 releasing effect Effects 0.000 description 3
239000001632 sodium acetate Substances 0.000 description 3
235000017281 sodium acetate Nutrition 0.000 description 3
239000001509 sodium citrate Substances 0.000 description 3
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
239000007787 solid Substances 0.000 description 3
230000001954 sterilising effect Effects 0.000 description 3
238000004659 sterilization and disinfection Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
210000005253 yeast cell Anatomy 0.000 description 3
LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 2
AQFATCCHOXBYNK-UHFFFAOYSA-N 2-piperidin-1-ium-1-ylethyl 1-cyclohexylcyclohexane-1-carboxylate;chloride Chemical compound [Cl-].C1CCCCC1(C1CCCCC1)C(=O)OCC[NH+]1CCCCC1 AQFATCCHOXBYNK-UHFFFAOYSA-N 0.000 description 2
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
108010025188 Alcohol oxidase Proteins 0.000 description 2
241000223602 Alternaria alternata Species 0.000 description 2
102000004400 Aminopeptidases Human genes 0.000 description 2
108090000915 Aminopeptidases Proteins 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
108020005544 Antisense RNA Proteins 0.000 description 2
241000125121 Aspergillus carbonarius Species 0.000 description 2
241000122824 Aspergillus ochraceus Species 0.000 description 2
108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
101800000778 Cytochrome b-c1 complex subunit 9 Proteins 0.000 description 2
102400000011 Cytochrome b-c1 complex subunit 9 Human genes 0.000 description 2
102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 2
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 2
108010082495 Dietary Plant Proteins Proteins 0.000 description 2
101100271445 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) atp9 gene Proteins 0.000 description 2
101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 2
239000001263 FEMA 3042 Substances 0.000 description 2
241000589565 Flavobacterium Species 0.000 description 2
102100022624 Glucoamylase Human genes 0.000 description 2
102000053187 Glucuronidase Human genes 0.000 description 2
108010060309 Glucuronidase Proteins 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
241000701024 Human betaherpesvirus 5 Species 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
108091092195 Intron Proteins 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
108090000364 Ligases Proteins 0.000 description 2
102000003960 Ligases Human genes 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 2
229930193140 Neomycin Natural products 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
241000228150 Penicillium chrysogenum Species 0.000 description 2
LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
241001545602 Phialophora mustea Species 0.000 description 2
102000011755 Phosphoglycerate Kinase Human genes 0.000 description 2
108700023219 Phosphoglycerate kinases Proteins 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
101710088675 Proline-rich peptide Proteins 0.000 description 2
241000589516 Pseudomonas Species 0.000 description 2
102000013009 Pyruvate Kinase Human genes 0.000 description 2
108020005115 Pyruvate Kinase Proteins 0.000 description 2
241000959173 Rasamsonia emersonii Species 0.000 description 2
241000235403 Rhizomucor miehei Species 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
244000300264 Spinacia oleracea Species 0.000 description 2
235000009337 Spinacia oleracea Nutrition 0.000 description 2
241001085826 Sporotrichum Species 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
239000012505 Superdex™ Substances 0.000 description 2
241000228341 Talaromyces Species 0.000 description 2
241001495429 Thielavia terrestris Species 0.000 description 2
241000223259 Trichoderma Species 0.000 description 2
241000499912 Trichoderma reesei Species 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
108010048241 acetamidase Proteins 0.000 description 2
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical group C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
239000013566 allergen Substances 0.000 description 2
230000002009 allergenic effect Effects 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
235000021120 animal protein Nutrition 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
UTXSFKPOIVELPQ-SFHVURJKSA-N benzyl n-[2-[(2s)-2-[(4-nitrophenyl)carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]carbamate Chemical compound C1=CC([N+](=O)[O-])=CC=C1NC(=O)[C@H]1N(C(=O)CNC(=O)OCC=2C=CC=CC=2)CCC1 UTXSFKPOIVELPQ-SFHVURJKSA-N 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
229940071162 caseinate Drugs 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
239000007979 citrate buffer Substances 0.000 description 2
238000012411 cloning technique Methods 0.000 description 2
239000003184 complementary RNA Substances 0.000 description 2
238000010276 construction Methods 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
-1 elongation factors Proteins 0.000 description 2
230000007071 enzymatic hydrolysis Effects 0.000 description 2
238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
235000020776 essential amino acid Nutrition 0.000 description 2
239000000284 extract Substances 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
239000008103 glucose Substances 0.000 description 2
230000012010 growth Effects 0.000 description 2
230000036541 health Effects 0.000 description 2
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
235000020256 human milk Nutrition 0.000 description 2
210000004251 human milk Anatomy 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
239000012535 impurity Substances 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
238000005040 ion trap Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
230000013011 mating Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
239000004570 mortar (masonry) Substances 0.000 description 2
239000013642 negative control Substances 0.000 description 2
229960004927 neomycin Drugs 0.000 description 2
238000012856 packing Methods 0.000 description 2
QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
230000008488 polyadenylation Effects 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
230000037452 priming Effects 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
230000007065 protein hydrolysis Effects 0.000 description 2
230000006920 protein precipitation Effects 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
238000003259 recombinant expression Methods 0.000 description 2
230000004044 response Effects 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
230000001953 sensory effect Effects 0.000 description 2
235000020183 skimmed milk Nutrition 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229940080237 sodium caseinate Drugs 0.000 description 2
229940071440 soy protein isolate Drugs 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
238000001694 spray drying Methods 0.000 description 2
239000008223 sterile water Substances 0.000 description 2
238000003756 stirring Methods 0.000 description 2
238000003860 storage Methods 0.000 description 2
230000009469 supplementation Effects 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
229920002258 tannic acid Polymers 0.000 description 2
LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
229940033123 tannic acid Drugs 0.000 description 2
235000015523 tannic acid Nutrition 0.000 description 2
UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
125000003508 trans-4-hydroxy-L-proline group Chemical group 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
239000003643 water by type Substances 0.000 description 2
235000008939 whole milk Nutrition 0.000 description 2
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
RCFJIAQLIRLKEN-BYPYZUCNSA-N (2s)-2-hydrazinyl-4-methylsulfanylbutanoic acid Chemical group CSCC[C@H](NN)C(O)=O RCFJIAQLIRLKEN-BYPYZUCNSA-N 0.000 description 1
KDXKERNSBIXSRK-RGXOIRHWSA-N (2s)-6-amino-2-(deuterioamino)hexanoic acid Chemical compound [2H]N[C@H](C(O)=O)CCCCN KDXKERNSBIXSRK-RGXOIRHWSA-N 0.000 description 1
KTCBLMXNWYGCRT-UHFFFAOYSA-N 1-[2-(1h-indol-3-yl)ethyl]-3-methylthiourea Chemical compound C1=CC=C2C(CCNC(=S)NC)=CNC2=C1 KTCBLMXNWYGCRT-UHFFFAOYSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
101710194912 18 kDa protein Proteins 0.000 description 1
PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
108010011619 6-Phytase Proteins 0.000 description 1
241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
241000607534 Aeromonas Species 0.000 description 1
241000589158 Agrobacterium Species 0.000 description 1
241000589155 Agrobacterium tumefaciens Species 0.000 description 1
102000015427 Angiotensins Human genes 0.000 description 1
108010064733 Angiotensins Proteins 0.000 description 1
108010042243 Aptamil Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
241000228215 Aspergillus aculeatus Species 0.000 description 1
241001513093 Aspergillus awamori Species 0.000 description 1
241000228195 Aspergillus ficuum Species 0.000 description 1
241000892910 Aspergillus foetidus Species 0.000 description 1
241001480052 Aspergillus japonicus Species 0.000 description 1
101100523058 Aspergillus niger pyrG gene Proteins 0.000 description 1
241000228232 Aspergillus tubingensis Species 0.000 description 1
101100317631 Aspergillus tubingensis xynA gene Proteins 0.000 description 1
108090000145 Bacillolysin Proteins 0.000 description 1
241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
241000193389 Bacillus thermoproteolyticus Species 0.000 description 1
241000606125 Bacteroides Species 0.000 description 1
241000486634 Bena Species 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
239000002028 Biomass Substances 0.000 description 1
108010006654 Bleomycin Proteins 0.000 description 1
241001274890 Boeremia exigua Species 0.000 description 1
102100037084 C4b-binding protein alpha chain Human genes 0.000 description 1
101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
241001533384 Circovirus Species 0.000 description 1
241000222290 Cladosporium Species 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
235000019750 Crude protein Nutrition 0.000 description 1
150000008574 D-amino acids Chemical class 0.000 description 1
108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
108030001574 Deuterolysin Proteins 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
101100240657 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) swoF gene Proteins 0.000 description 1
101710124086 Envelope protein UL45 Proteins 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
101710089384 Extracellular protease Proteins 0.000 description 1
108700005088 Fungal Genes Proteins 0.000 description 1
108010058643 Fungal Proteins Proteins 0.000 description 1
241000223218 Fusarium Species 0.000 description 1
241000223195 Fusarium graminearum Species 0.000 description 1
102100039556 Galectin-4 Human genes 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
108700007698 Genetic Terminator Regions Proteins 0.000 description 1
108050008938 Glucoamylases Proteins 0.000 description 1
241000395074 Graphiopsis chlorocephala Species 0.000 description 1
101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 1
206010019345 Heat stroke Diseases 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
238000011993 High Performance Size Exclusion Chromatography Methods 0.000 description 1
108010033040 Histones Proteins 0.000 description 1
101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 1
241000341655 Human papillomavirus type 16 Species 0.000 description 1
206010053317 Hydrophobia Diseases 0.000 description 1
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
101710203526 Integrase Proteins 0.000 description 1
241000170280 Kluyveromyces sp. Species 0.000 description 1
241000235058 Komagataella pastoris Species 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
101150022713 LAC4 gene Proteins 0.000 description 1
108010059881 Lactase Proteins 0.000 description 1
101710128836 Large T antigen Proteins 0.000 description 1
241001263406 Lecanicillium psalliotae Species 0.000 description 1
101100536883 Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) thi5 gene Proteins 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
241000989306 Lophophyton gallinae Species 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
240000002129 Malva sylvestris Species 0.000 description 1
235000006770 Malva sylvestris Nutrition 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
102100021833 Mesencephalic astrocyte-derived neurotrophic factor Human genes 0.000 description 1
101710155665 Mesencephalic astrocyte-derived neurotrophic factor Proteins 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
108700005443 Microbial Genes Proteins 0.000 description 1
229920001410 Microfiber Polymers 0.000 description 1
208000009793 Milk Hypersensitivity Diseases 0.000 description 1
102100035854 N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 Human genes 0.000 description 1
108050006009 N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 Proteins 0.000 description 1
108050004975 N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 Proteins 0.000 description 1
102100036658 N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 Human genes 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
241000221960 Neurospora Species 0.000 description 1
241000221961 Neurospora crassa Species 0.000 description 1
101100240662 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) gtt-1 gene Proteins 0.000 description 1
102000035092 Neutral proteases Human genes 0.000 description 1
108091005507 Neutral proteases Proteins 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
101150043338 Nmt1 gene Proteins 0.000 description 1
108020004711 Nucleic Acid Probes Proteins 0.000 description 1
241000320412 Ogataea angusta Species 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
102100037214 Orotidine 5'-phosphate decarboxylase Human genes 0.000 description 1
108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
102100034574 P protein Human genes 0.000 description 1
101710181008 P protein Proteins 0.000 description 1
108010019160 Pancreatin Proteins 0.000 description 1
241000228143 Penicillium Species 0.000 description 1
239000001888 Peptone Substances 0.000 description 1
108010080698 Peptones Proteins 0.000 description 1
101710163504 Phaseolin Proteins 0.000 description 1
101710177166 Phosphoprotein Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
108010039918 Polylysine Chemical group 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
101710136733 Proline-rich protein Proteins 0.000 description 1
239000012564 Q sepharose fast flow resin Substances 0.000 description 1
206010037742 Rabies Diseases 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000002278 Ribosomal Proteins Human genes 0.000 description 1
108010000605 Ribosomal Proteins Proteins 0.000 description 1
108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
238000010847 SEQUEST Methods 0.000 description 1
241000228417 Sarocladium strictum Species 0.000 description 1
241000235346 Schizosaccharomyces Species 0.000 description 1
241000235347 Schizosaccharomyces pombe Species 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
240000006394 Sorghum bicolor Species 0.000 description 1
235000011684 Sorghum saccharatum Nutrition 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
235000019764 Soybean Meal Nutrition 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 1
239000008049 TAE buffer Substances 0.000 description 1
241000228178 Thermoascus Species 0.000 description 1
241001494489 Thielavia Species 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
241000589634 Xanthomonas Species 0.000 description 1
241000235013 Yarrowia Species 0.000 description 1
241000235015 Yarrowia lipolytica Species 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
210000001361 achilles tendon Anatomy 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000011149 active material Substances 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000032683 aging Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
108010063123 alfare Proteins 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
108090000637 alpha-Amylases Proteins 0.000 description 1
102000004139 alpha-Amylases Human genes 0.000 description 1
229940024171 alpha-amylase Drugs 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
101150078331 ama-1 gene Proteins 0.000 description 1
101150069003 amdS gene Proteins 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
229940025131 amylases Drugs 0.000 description 1
230000000578 anorexic effect Effects 0.000 description 1
230000002785 anti-thrombosis Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
101150008194 argB gene Proteins 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
229960001561 bleomycin Drugs 0.000 description 1
OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
238000009835 boiling Methods 0.000 description 1
235000008429 bread Nutrition 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
210000004900 c-terminal fragment Anatomy 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
229910052793 cadmium Inorganic materials 0.000 description 1
BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
101150014229 carA gene Proteins 0.000 description 1
101150070764 carB gene Proteins 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
125000004112 carboxyamino group Chemical group [H]OC(=O)N([H])[*] 0.000 description 1
229940021722 caseins Drugs 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000036978 cell physiology Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000011097 chromatography purification Methods 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
238000012258 culturing Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
230000007547 defect Effects 0.000 description 1
239000013530 defoamer Substances 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
238000002050 diffraction method Methods 0.000 description 1
235000019621 digestibility Nutrition 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
108010083141 dipeptidyl carboxypeptidase Proteins 0.000 description 1
PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000000504 effect on taste Effects 0.000 description 1
239000003480 eluent Substances 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000003511 endothelial effect Effects 0.000 description 1
238000007824 enzymatic assay Methods 0.000 description 1
230000006862 enzymatic digestion Effects 0.000 description 1
239000006167 equilibration buffer Substances 0.000 description 1
239000003797 essential amino acid Substances 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
101150097026 facA gene Proteins 0.000 description 1
239000003527 fibrinolytic agent Substances 0.000 description 1
230000003480 fibrinolytic effect Effects 0.000 description 1
235000019688 fish Nutrition 0.000 description 1
238000005189 flocculation Methods 0.000 description 1
230000016615 flocculation Effects 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
238000009472 formulation Methods 0.000 description 1
235000020548 fortified fruit juice Nutrition 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
210000001156 gastric mucosa Anatomy 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
230000002414 glycolytic effect Effects 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
101150073906 gpdA gene Proteins 0.000 description 1
239000004519 grease Substances 0.000 description 1
235000001497 healthy food Nutrition 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
229940094991 herring sperm dna Drugs 0.000 description 1
150000004678 hydrides Chemical class 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
230000001631 hypertensive effect Effects 0.000 description 1
230000000774 hypoallergenic effect Effects 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000009851 immunogenic response Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000003262 industrial enzyme Substances 0.000 description 1
235000021125 infant nutrition Nutrition 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
238000013383 initial experiment Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
230000010354 integration Effects 0.000 description 1
PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
238000002372 labelling Methods 0.000 description 1
229940116108 lactase Drugs 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
101150039489 lysZ gene Proteins 0.000 description 1
238000002803 maceration Methods 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
230000006609 metabolic stress Effects 0.000 description 1
SJFKGZZCMREBQH-UHFFFAOYSA-N methyl ethanimidate Chemical compound COC(C)=N SJFKGZZCMREBQH-UHFFFAOYSA-N 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
239000003658 microfiber Substances 0.000 description 1
235000020166 milkshake Nutrition 0.000 description 1
235000013379 molasses Nutrition 0.000 description 1
239000003068 molecular probe Substances 0.000 description 1
230000035772 mutation Effects 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
101150095344 niaD gene Proteins 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
239000002853 nucleic acid probe Substances 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
239000002417 nutraceutical Substances 0.000 description 1
235000021436 nutraceutical agent Nutrition 0.000 description 1
125000001477 organic nitrogen group Chemical group 0.000 description 1
201000009868 osmotic diarrhea Diseases 0.000 description 1
208000028719 osmotic diarrheal disease Diseases 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000005022 packaging material Substances 0.000 description 1
235000019629 palatability Nutrition 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
229940055695 pancreatin Drugs 0.000 description 1
235000015927 pasta Nutrition 0.000 description 1
229940066734 peptide hydrolases Drugs 0.000 description 1
235000019319 peptone Nutrition 0.000 description 1
LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
229940117953 phenylisothiocyanate Drugs 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
229940085127 phytase Drugs 0.000 description 1
239000003375 plant hormone Substances 0.000 description 1
230000037039 plant physiology Effects 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920002704 polyhistidine Polymers 0.000 description 1
229920000656 polylysine Chemical group 0.000 description 1
150000008442 polyphenolic compounds Chemical class 0.000 description 1
235000013824 polyphenols Nutrition 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
239000001965 potato dextrose agar Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
239000012460 protein solution Substances 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
101150054232 pyrG gene Proteins 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
239000002994 raw material Substances 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
238000005932 reductive alkylation reaction Methods 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000009711 regulatory function Effects 0.000 description 1
229940108461 rennet Drugs 0.000 description 1
108010058314 rennet Proteins 0.000 description 1
238000011160 research Methods 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000005070 ripening Effects 0.000 description 1
239000010979 ruby Substances 0.000 description 1
229910001750 ruby Inorganic materials 0.000 description 1
239000007974 sodium acetate buffer Substances 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
239000012279 sodium borohydride Substances 0.000 description 1
229910000033 sodium borohydride Inorganic materials 0.000 description 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
239000004455 soybean meal Substances 0.000 description 1
235000013599 spices Nutrition 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
230000009747 swallowing Effects 0.000 description 1
230000008685 targeting Effects 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229920001187 thermosetting polymer Polymers 0.000 description 1
230000008719 thickening Effects 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
238000003151 transfection method Methods 0.000 description 1
238000011426 transformation method Methods 0.000 description 1
238000013519 translation Methods 0.000 description 1
101150016309 trpC gene Proteins 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
101150101900 uidA gene Proteins 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
238000005406 washing Methods 0.000 description 1
235000015099 wheat brans Nutrition 0.000 description 1
101150077833 xlnA gene Proteins 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
- A23J3/16—Vegetable proteins from soybean
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/346—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of vegetable proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12H—PASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION OR AGEING OF ALCOHOLIC BEVERAGES; METHODS FOR ALTERING THE ALCOHOL CONTENT OF FERMENTED SOLUTIONS OR ALCOHOLIC BEVERAGES
- C12H1/00—Pasteurisation, sterilisation, preservation, purification, clarification, or ageing of alcoholic beverages
- C12H1/003—Pasteurisation, sterilisation, preservation, purification, clarification, or ageing of alcoholic beverages by a biochemical process
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/38—Assays involving biological materials from specific organisms or of a specific nature from fungi from Aspergillus

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Chemical Kinetics & Catalysis (AREA)
Physics & Mathematics (AREA)
Cell Biology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Pathology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Physiology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Botany (AREA)
Pediatric Medicine (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)

ES01985386T 2000-12-07 2001-12-06 Hidrolizados proteicos enriquecidos en peptidos que tienen un resto de prolina carboxi terminal. Expired - Lifetime ES2347320T3 (es)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP00204404		2000-12-07
EP00204404		2000-12-07
EP01204464		2001-11-15
EP01204464		2001-11-15

Publications (1)

Publication Number	Publication Date
ES2347320T3 true ES2347320T3 (es)	2010-10-28

Family

ID=26072896

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES01985386T Expired - Lifetime ES2347320T3 (es)	2000-12-07	2001-12-06	Hidrolizados proteicos enriquecidos en peptidos que tienen un resto de prolina carboxi terminal.
ES01999290T Expired - Lifetime ES2301579T3 (es)	2000-12-07	2001-12-06	Prolil endoproteasa a partir de aspergillus niger.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
ES01999290T Expired - Lifetime ES2301579T3 (es)	2000-12-07	2001-12-06	Prolil endoproteasa a partir de aspergillus niger.

Country Status (17)

Country	Link
US (3)	US7309595B2 (de)
EP (3)	EP2175013A1 (de)
JP (3)	JP4559023B2 (de)
KR (3)	KR20030085112A (de)
CN (2)	CN1300328C (de)
AT (2)	ATE386110T1 (de)
AU (3)	AU3456102A (de)
BR (2)	BR0116003A (de)
CA (2)	CA2430893C (de)
CY (1)	CY1111322T1 (de)
DE (2)	DE60132801T2 (de)
DK (2)	DK1383393T3 (de)
ES (2)	ES2347320T3 (de)
MX (2)	MXPA03005128A (de)
NZ (2)	NZ526271A (de)
PT (1)	PT1383393E (de)
WO (2)	WO2002045524A2 (de)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1326957B1 (de)	2000-12-07	2004-05-06	DSM IP Assets B.V.	Verfahren zur verhinderung oder verminderung der trübung in getränken
KR20030085112A (ko) *	2000-12-07	2003-11-03	디에스엠 아이피 어셋츠 비.브이.	카르복시 말단 프롤린 잔기를 갖는 펩티드가 풍부한단백질 가수분해물
CN100582226C (zh) *	2001-02-23	2010-01-20	Dsmip资产有限公司	编码新蛋白水解酶的新基因
NZ530165A (en)	2001-07-18	2004-08-27	Dsm Ip Assets B	Process for the hydrolysis of milk proteins
US7320788B2 (en) *	2002-02-14	2008-01-22	The Board Of Trustees Of The Leland Stanford Junior University	Enzyme treatment of foodstuffs for Celiac Sprue
ATE505201T1 (de) *	2002-02-14	2011-04-15	Univ Leland Stanford Junior	Enzymbehandlung von nahrungsmitteln für zöliakie- sprue
US8143210B2 (en) *	2002-02-14	2012-03-27	The Board Of Trustees Of The Leland Stanford Junior University	Enzyme treatment of foodstuffs for celiac sprue
US7462688B2 (en) *	2002-05-14	2008-12-09	The Board Of Trustees Of The Leland Stanford Junior University	Peptides for diagnostic and therapeutic methods for celiac sprue
US7202216B2 (en) *	2002-05-14	2007-04-10	The Board Of Trustees Of The Leland Stanford Junior University	Drug therapy for celiac sprue
US7265093B2 (en) *	2002-05-14	2007-09-04	The Board Of Trustees Of The Leland Stanford Junior University	Drug therapy for Celiac Sprue
US7605150B2 (en) *	2002-05-14	2009-10-20	The Board Of Trustees Of The Leland Stanford Junior University	Drug therapy for Celiac Sprue
AU2003236689A1 (en)	2002-06-04	2003-12-19	Dsm Ip Assets B.V.	Protein hydrolysate rich in tripeptides
ES2525873T3 (es) *	2002-06-07	2014-12-30	Dsm Ip Assets B.V.	Método mejorado para la prevención o reducción del enturbiamiento en bebidas
JP4719465B2 (ja) *	2002-09-04	2011-07-06	ディーエスエムアイピーアセッツビー．ブイ．	インスリン感受性増強剤およびペプチド画分を含む栄養補給用および治療用組成物
DE60217188T2 (de)	2002-09-06	2007-10-04	Telefonaktiebolaget Lm Ericsson (Publ)	Zusammengesetzter leistungsverstärker
CA2502700C (en) *	2002-11-20	2017-01-17	Chaitan Khosla	Diagnostic method for celiac sprue
DE10331202A1 (de)	2003-07-10	2005-03-31	S.K. Enterprise Gmbh	Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
DK1663298T3 (da)	2003-09-23	2019-10-14	Dsm Ip Assets Bv	Anvendelse af prolinspecifikke endoproteaser til hydrolyse af peptider og proteiner
US7579313B2 (en) *	2003-11-18	2009-08-25	The Board Of Trustees Of The Leland Stanford Junior University	Transglutaminase inhibitors and methods of use thereof
CN101218348B (zh)	2004-04-02	2014-07-30	帝斯曼知识产权资产管理有限公司	具有提高的同源重组效率的丝状真菌突变体
US7628985B2 (en) *	2004-04-26	2009-12-08	The Board Of Regents Of The Leland Stanford Junior University	Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US7563864B2 (en) *	2004-04-26	2009-07-21	Celiac Sprue Research Foundation	Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
US7534426B2 (en) *	2004-04-26	2009-05-19	The Board Of Trustees Of The Leland Stanford Junior University	Glutenase enzyme assays
WO2005117595A1 (en) *	2004-06-04	2005-12-15	Dsm Ip Assets B.V.	Method to improve flavour of baked cereal products
JP2008504319A (ja) *	2004-06-28	2008-02-14	ディーエスエムアイピーアセッツビー．ブイ．	タンパク質水解物を含有する化粧品組成物
EP1773864A4 (de) *	2004-07-31	2009-02-18	Biogrand Co Ltd	Seidenpeptid, das neuroprotektive und neurofunktionelle wirkungen verbessert, und verfahren zu dessen herstellung
NL1026931C2 (nl) *	2004-08-31	2006-03-01	Friesland Brands Bv	ACE-remmende wei-hydrolysaten.
JP5106117B2 (ja) *	2004-12-22	2012-12-26	ディーエスエムアイピーアセッツビー．ブイ．	単一の酵素工程における血圧降下ペプチド
ES2381118T3 (es) *	2004-12-23	2012-05-23	Campina Nederland Holding B.V.	Hidrolizado de proteínas enriquecido en péptidos de inhibición de DPP-IV y su uso
WO2006082922A1 (ja) *	2005-02-03	2006-08-10	San-Ei Gen F.F.I., Inc.	色調が改善されたクチナシ青色素とその製造方法
NZ560601A (en) *	2005-02-24	2009-09-25	Dsm Ip Assets Bv	Process to produce IPP tripeptide from glycomacropeptide using proline specific proteolytic enzyme
EP2439266B1 (de)	2005-11-28	2017-02-01	DSM IP Assets B.V.	Enzympräparate zur Abgabe eines schlechten Geschmacks
JP2009517464A (ja)	2005-11-30	2009-04-30	カンピーナネーダーランドホールディングビー．ブイ．	グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用
DE102006004714A1 (de) *	2006-01-31	2007-08-02	Henkel Kgaa	Pflegende Haarbehandlungsmittel mit Proteinhydrolysat(en)
CN101511211A (zh) *	2006-02-02	2009-08-19	帝斯曼知识产权资产管理有限公司	包含脯氨酸特异性蛋白酶的食物产品
WO2007113279A1 (en)	2006-03-31	2007-10-11	Dsm Ip Assets B.V.	Process for the hydrolysis of milk proteins
RU2008144426A (ru) *	2006-04-11	2010-05-20	Милеутис Лтд. (Il)	Регулирование репродуктивной эффективности сельскохозяйственных животных
WO2007122210A2 (en) *	2006-04-25	2007-11-01	Dsm Ip Assets B.V.	Proline-specific proteases free from amylolytic activities
EP3868855A1 (de) *	2006-07-13	2021-08-25	DSM IP Assets B.V.	Verbessertes brauverfahren
DE102006036285A1 (de) *	2006-08-03	2008-02-07	"S.U.K." Beteiligungs Gmbh	Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
EP2511372A1 (de)	2006-11-02	2012-10-17	DSM IP Assets B.V.	Verbesserte Herstellung von sekretierten Proteinen durch filamentöse Pilze
MX2009009780A (es) *	2007-03-16	2010-05-20	Univ Leland Stanford Junior	Terapia de enzima de combinacion para la digestion de gluten dietetico.
DK2181191T3 (da) *	2007-08-20	2011-05-23	Novozymes As	Nukleasereduktion
CN101294153B (zh) *	2007-11-22	2011-05-04	天津科技大学	一种黑曲霉脯氨酸蛋白内肽酶及其制备方法
US20110112201A1 (en)	2008-04-17	2011-05-12	Jiankang Liu	Hydroxytyrosol benefits mitochondria
US20110097448A1 (en) *	2008-06-20	2011-04-28	Solae, Llc	Protein Hydrolysate Compositions Stable Under Acidic Conditions
WO2010009400A1 (en) *	2008-07-18	2010-01-21	Novozymes A/S	Method for preparing a protein hydrolysate
US8498729B2 (en) *	2008-08-29	2013-07-30	Smp Logic Systems Llc	Manufacturing execution system for use in manufacturing baby formula
US9055752B2 (en)	2008-11-06	2015-06-16	Intercontinental Great Brands Llc	Shelf-stable concentrated dairy liquids and methods of forming thereof
US20120045542A1 (en) *	2009-05-18	2012-02-23	Dsm Ip Assets B.V.	Process to produce a wine or fruit juice stabliser
WO2011000773A1 (en)	2009-07-02	2011-01-06	Dsm Ip Assets B.V.	Testing efficacy for celiac disease
EP2515932A2 (de) *	2009-12-21	2012-10-31	Centre Hospitalier Universitaire Vaudois (CHUV)	Synergetische wirkung einer prolylprotease und tripeptidylproteasen
GB201012539D0 (en) *	2010-07-27	2010-09-08	Savantium Ltd	Nutritional compositions
UA112972C2 (uk)	2010-09-08	2016-11-25	Інтерконтінентал Грейт Брендс ЛЛС	Рідкий молочний концентрат з високим вмістом сухих речовин
WO2013056038A2 (en) *	2011-10-14	2013-04-18	Abbott Laboratories	Sterilized liquid protein supplement
CN104159457B (zh) *	2012-03-09	2016-08-17	株式会社明治	水分吸收性优异的饮食品
ES2444299B1 (es)	2012-08-23	2014-12-12	Nutrición Técnica Deportiva, S.L.	Uso de un hidrolizado de caseina como agente antiherpético
WO2014060495A1 (en)	2012-10-19	2014-04-24	Dsm Ip Assets B.V.	Process for the production of an infant formula
US9820504B2 (en)	2013-03-08	2017-11-21	Axiom Foods, Inc.	Rice protein supplement and methods of use thereof
NZ711956A (en)	2013-03-08	2018-06-29	Axiom Foods Inc	Rice protein supplements
KR20160035587A (ko)	2013-07-10	2016-03-31	노파르티스 아게	복수개의 프로테아제 결핍 사상형 진균 세포들 및 그의 이용방법
US9530146B2 (en) *	2013-09-05	2016-12-27	Dsm Ip Assets B.V.	Marketing the use of an acidic soft drink to enhance the efficacy of a gluten-digesting enzyme
WO2015032620A1 (en)	2013-09-05	2015-03-12	Dsm Ip Assets B.V.	Use of an acidic soft drink to enhance the efficacy of a gluten-digesting enzyme
ES2544153B1 (es) *	2014-02-24	2016-06-06	Ntd Labs, S.L.	Uso de un hidrolizado de caseína como agente antiviral
EA034253B1 (ru) *	2014-05-19	2020-01-22	ДСМ АйПи АССЕТС Б.В.	Пролин-специфическая эндопротеаза
ES2718071T3 (es) *	2014-06-03	2019-06-27	Dsm Ip Assets Bv	Endoproteasa específica para prolina y su uso
JP6244601B2 (ja) *	2014-07-01	2017-12-13	ディーエスエムアイピーアセッツビー．ブイ．	低グルテン酵母加水分解産物
CN108064266A (zh)	2014-07-21	2018-05-22	格利科斯芬兰公司	在丝状真菌中具有哺乳动物样n-聚糖的糖蛋白的制备
JP6505211B2 (ja) *	2015-04-30	2019-04-24	チャイナナショナルリサーチインスティテュートオブフードアンドファーメンテーションインダストリーズ	低アレルギー誘発性で苦味の低下した大豆オリゴペプチド、その調製方法、およびその用途
HUE044665T2 (hu) *	2016-09-01	2019-11-28	Metax Inst Fuer Diaetetik Gmbh	Fenilalanin-mentes fehérje PKU (fenilketonuria) kezelésére
JP2018057346A (ja) *	2016-10-07	2018-04-12	森永乳業株式会社	カゼイン酵素処理物及びその製造方法
CN108064937A (zh) *	2016-11-15	2018-05-25	内蒙古伊利实业集团股份有限公司	利用脯氨酸内切酶改性的饮用型发酵乳制品及其制备方法
CN106754837B (zh) *	2016-12-09	2020-04-14	青岛蔚蓝生物集团有限公司	一种脯氨酸蛋白酶突变体及其应用
CN106635845B (zh) *	2016-12-09	2020-04-14	青岛蔚蓝生物集团有限公司	一种高产脯氨酸蛋白酶的黑曲霉菌株
CN108588060B (zh) *	2017-03-07	2020-12-01	武汉康复得生物科技股份有限公司	一种用丝状真菌宿主细胞表达的重组草酸脱羧酶
JP2018184367A (ja) *	2017-04-26	2018-11-22	国立大学法人京都大学	ペプチド
EP3634155A4 (de) *	2017-05-12	2021-02-17	Axiom Foods Inc.	Reisprodukte sowie systeme und verfahren zu deren herstellung
WO2018224035A1 (en)	2017-06-09	2018-12-13	Novozymes A/S	Polypeptide, use and method for hydrolysing protein
KR20190081232A (ko)	2017-12-29	2019-07-09	토탈바이오 주식회사	곤충(귀뚜라미)의 단백질과 산야초 추출물의 혼합물를 피부 미백, 세포재생, 보습 유효성분으로 포함하는 화장품 조성물
CN109486707B (zh) *	2018-11-23	2021-11-02	北京林业大学	一种枯草芽孢杆菌菌株及其应用
WO2020120737A1 (en)	2018-12-13	2020-06-18	Dsm Ip Assets B.V.	Umami flavour composition
BR112021020746A2 (pt) *	2019-05-13	2021-12-14	Nestle Sa	Composições e métodos para tratar ou evitar fadiga metabólica usando no composto oleuropeína ou um metabólito da mesma
CN112680371A (zh) *	2019-10-18	2021-04-20	广东利世康低碳科技有限公司	一种水解餐厨垃圾中蛋白成分的产朊假丝酵母双基因共表达菌株及其构建方法
JP7682857B2 (ja) *	2020-04-07	2025-05-26	新田ゼラチン株式会社	ペプチド組成物およびその製造方法
WO2021254943A1 (en)	2020-06-17	2021-12-23	Dsm Ip Assets B.V.	Umami flavour composition
CN112126668B (zh) *	2020-09-09	2024-03-01	宁波希诺亚海洋生物科技有限公司	一种特异性内切复合酶制备无苦味大豆多肽的方法
CA3191387A1 (en)	2020-09-30	2022-04-07	Nobell Foods, Inc.	Recombinant milk proteins and food compositions comprising the same
US10947552B1 (en)	2020-09-30	2021-03-16	Alpine Roads, Inc.	Recombinant fusion proteins for producing milk proteins in plants
CN118043454A (zh) *	2021-06-18	2024-05-14	国际N&H丹麦有限公司	用于啤酒浑浊减少的蛋白酶
ES2940736B2 (es)	2021-11-09	2023-09-19	Ntd Labs S L U	Uso combinado de imiquimod y de un hidrolizado de caseina para el tratamiento de condilomas
US20250019626A1 (en)	2021-11-30	2025-01-16	Dsm Ip Assets B.V.	Improved beverage production process
WO2023148301A1 (en)	2022-02-02	2023-08-10	Biotalys NV	Modified microbial cells and uses thereof
WO2024126712A1 (en) *	2022-12-14	2024-06-20	Dsm Ip Assets B.V.	Process for preparing hydrolyzed vegetable proteins
CN116162556A (zh) *	2023-02-01	2023-05-26	北京中科欣扬生物科技有限公司	一种高产黑曲霉脯氨酸内切蛋白酶的制备方法
EP4437856A1 (de) *	2023-03-31	2024-10-02	DSM IP Assets B.V.	Neue enzymzusammensetzung und neues bierbrauverfahren
WO2026003044A1 (en)	2024-06-25	2026-01-02	Ntd Labs, S.L.	Casein hydrolysate for treating crohn's disease

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE55817B1 (en)	1982-05-19	1991-01-30	Gist Brocades Nv	Cloning system for kluyveromyces species
ES8608579A1 (es)	1983-07-06	1986-06-16	Gist Brocades Nv	Procedimiento para introducir dna en un anfitrion de cepa de microorganismo unicelular
US4885249A (en)	1984-12-05	1989-12-05	Allelix, Inc.	Aspergillus niger transformation system
ATE253119T1 (de)	1985-04-15	2003-11-15	Dsm Ip Assets Bv	Verwendung des glucoamylasepromotors aus apergillus
GB8528100D0 (en)	1985-11-14	1985-12-18	Imp Biotechnology	Zenymatic hydrolysis of proteins
NO872932L (no)	1986-07-18	1988-01-19	Gist Brocades Nv	Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika.
JPS6386485A (ja)	1986-09-30	1988-04-16	Agency Of Ind Science & Technol	トンネル型ジヨセフソン接合素子
ES2061632T5 (es)	1987-07-28	2000-12-16	Dsm Nv	Kluyveromyces como celula hospedante.
EP0321603A1 (de)	1987-12-23	1989-06-28	Societe Des Produits Nestle S.A.	Verfahren zur Herstellung eines Molke-Eiweisshydrolysates und eines hypoallergenen Nahrungsmittels
EP0325986A3 (de)	1988-01-28	1989-10-11	Miles Inc.	Enzymatische Hydrolyse von Proteinen
JPH0630615B2 (ja)	1988-07-27	1994-04-27	江崎グリコ株式会社	低分子ペプチド組成物及びその製造方法
JP2862418B2 (ja) *	1990-09-20	1999-03-03	森永乳業株式会社	脂質代謝改善に有効な機能性食品
JPH04297923A (ja) *	1991-03-27	1992-10-21	Nec Software Kansai Ltd	文字コード変換方式
JPH051314A (ja)	1991-06-24	1993-01-08	Kawasaki Steel Corp	光フアイバ式温度分布測定装置
JPH0614776A (ja)	1991-07-04	1994-01-25	Fuji Oil Co Ltd	プロリルエンドペプチダーゼ及びその製造方法
JP3010795B2 (ja) *	1991-07-04	2000-02-21	不二製油株式会社	ペプチドの苦味除去方法
ATE237689T1 (de)	1991-07-24	2003-05-15	Novartis Pharma Gmbh	Dna kodierend für propylendopeptidase und dessen verwendung
JPH07115969A (ja)	1993-10-25	1995-05-09	Asahi Chem Ind Co Ltd	加水分解蛋白質の製造方法
EP0785726B1 (de)	1994-10-26	2004-01-07	Novozymes A/S	Verfahren für die herstellung eines milch-protein-hydrolysates
DE19502168C1 (de) *	1995-01-25	1996-06-27	Henkel Kgaa	Verfahren zur Herstellung von Weizenproteinhydrolysaten
JPH09164A (ja) *	1995-06-22	1997-01-07	Asahi Chem Ind Co Ltd	加水分解蛋白質の製造方法
JP3171560B2 (ja) *	1996-05-21	2001-05-28	仁苅野	ヘテロポリ酸触媒
WO1998014599A1 (en) *	1996-10-04	1998-04-09	Novo Nordisk Biotech, Inc.	Carboxypeptidases from aspergillus oryzae and nucleic acids encoding same
WO1998027827A1 (en) *	1996-12-23	1998-07-02	Dsm N.V.	Method for producing a protein hydrolysate
US6432672B1 (en)	1997-04-11	2002-08-13	Gerardus Cornelis Maria Selten	Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
DE69838106T2 (de)	1997-12-22	2008-04-03	Dsm Ip Assets B.V.	Expressionsklonierung in filamentösen pilzen
WO1999038956A2 (en)	1998-01-30	1999-08-05	Institut National De La Recherche Agronomique	Enzyme modifying rhamnogalacturonane ii, dna encoding for said enzymes and method for producing the enzyme
JPH11221024A (ja) *	1998-02-06	1999-08-17	Fuji Oil Co Ltd	ポリペプチド、ポリペプチド混合物及び乳化剤
JPH11225686A (ja) *	1998-02-10	1999-08-24	Morinaga Milk Ind Co Ltd	カゼイン加水分解物及びその製造方法
JPH11243866A (ja)	1998-03-05	1999-09-14	Morinaga Milk Ind Co Ltd	カゼイン加水分解物及びその製造法
CN1137261C (zh) *	1999-02-12	2004-02-04	中国科学院上海生物工程研究中心	点状产气单胞菌脯氨酰内肽酶及其制法和用途
EP1326957B1 (de)	2000-12-07	2004-05-06	DSM IP Assets B.V.	Verfahren zur verhinderung oder verminderung der trübung in getränken
KR20030085112A (ko)	2000-12-07	2003-11-03	디에스엠 아이피 어셋츠 비.브이.	카르복시 말단 프롤린 잔기를 갖는 펩티드가 풍부한단백질 가수분해물
CN100582226C (zh) *	2001-02-23	2010-01-20	Dsmip资产有限公司	编码新蛋白水解酶的新基因

2001
- 2001-12-06 KR KR10-2003-7007576A patent/KR20030085112A/ko not_active Ceased
- 2001-12-06 KR KR1020037007577A patent/KR100867059B1/ko not_active Expired - Lifetime
- 2001-12-06 WO PCT/EP2001/014480 patent/WO2002045524A2/en not_active Ceased
- 2001-12-06 AU AU3456102A patent/AU3456102A/xx active Pending
- 2001-12-06 US US10/450,185 patent/US7309595B2/en not_active Expired - Lifetime
- 2001-12-06 WO PCT/EP2001/014479 patent/WO2002045523A2/en not_active Ceased
- 2001-12-06 CN CNB018216021A patent/CN1300328C/zh not_active Expired - Fee Related
- 2001-12-06 MX MXPA03005128A patent/MXPA03005128A/es active IP Right Grant
- 2001-12-06 CN CNB01821603XA patent/CN100506981C/zh not_active Expired - Lifetime
- 2001-12-06 EP EP09180199A patent/EP2175013A1/de not_active Withdrawn
- 2001-12-06 CA CA2430893A patent/CA2430893C/en not_active Expired - Lifetime
- 2001-12-06 JP JP2002547323A patent/JP4559023B2/ja not_active Expired - Fee Related
- 2001-12-06 AU AU1608902A patent/AU1608902A/xx active Pending
- 2001-12-06 DE DE60132801T patent/DE60132801T2/de not_active Expired - Lifetime
- 2001-12-06 US US10/433,747 patent/US7608697B2/en not_active Expired - Fee Related
- 2001-12-06 ES ES01985386T patent/ES2347320T3/es not_active Expired - Lifetime
- 2001-12-06 AT AT01999290T patent/ATE386110T1/de not_active IP Right Cessation
- 2001-12-06 KR KR1020087029681A patent/KR100905849B1/ko not_active Expired - Fee Related
- 2001-12-06 PT PT01985386T patent/PT1383393E/pt unknown
- 2001-12-06 JP JP2002547324A patent/JP4119248B2/ja not_active Expired - Lifetime
- 2001-12-06 EP EP01999290A patent/EP1339837B1/de not_active Expired - Lifetime
- 2001-12-06 BR BR0116003-6A patent/BR0116003A/pt not_active Application Discontinuation
- 2001-12-06 DK DK01985386.0T patent/DK1383393T3/da active
- 2001-12-06 DE DE60142704T patent/DE60142704D1/de not_active Expired - Lifetime
- 2001-12-06 DK DK01999290T patent/DK1339837T3/da active
- 2001-12-06 NZ NZ526271A patent/NZ526271A/en not_active IP Right Cessation
- 2001-12-06 CA CA2437081A patent/CA2437081C/en not_active Expired - Lifetime
- 2001-12-06 AU AU2002234561A patent/AU2002234561B2/en not_active Ceased
- 2001-12-06 EP EP01985386A patent/EP1383393B1/de not_active Expired - Lifetime
- 2001-12-06 AT AT01985386T patent/ATE475324T1/de active
- 2001-12-06 ES ES01999290T patent/ES2301579T3/es not_active Expired - Lifetime
- 2001-12-06 BR BRPI0116036A patent/BRPI0116036B1/pt active IP Right Grant
- 2001-12-06 MX MXPA03005127A patent/MXPA03005127A/es active IP Right Grant
- 2001-12-06 NZ NZ526270A patent/NZ526270A/en not_active IP Right Cessation
2009
- 2009-09-17 US US12/585,548 patent/US20100112635A1/en not_active Abandoned
2010
- 2010-03-30 JP JP2010078003A patent/JP4991897B2/ja not_active Expired - Fee Related
- 2010-10-27 CY CY20101100975T patent/CY1111322T1/el unknown

Also Published As

Publication number	Publication date
AU3456102A (en)	2002-06-18
BRPI0116036B1 (pt)	2016-03-08
EP1383393B1 (de)	2010-07-28
JP4119248B2 (ja)	2008-07-16
CN1300328C (zh)	2007-02-14
ATE386110T1 (de)	2008-03-15
CA2437081A1 (en)	2002-06-13
WO2002045524A2 (en)	2002-06-13
EP2175013A1 (de)	2010-04-14
AU1608902A (en)	2002-06-18
AU2002234561B2 (en)	2007-01-18
CN100506981C (zh)	2009-07-01
ATE475324T1 (de)	2010-08-15
CN1484694A (zh)	2004-03-24
KR100905849B1 (ko)	2009-07-02
BR0116003A (pt)	2004-03-30
JP4559023B2 (ja)	2010-10-06
WO2002045523A3 (en)	2003-01-30
JP2004517832A (ja)	2004-06-17
JP2004519221A (ja)	2004-07-02
US20040241791A1 (en)	2004-12-02
NZ526270A (en)	2004-11-26
WO2002045523A2 (en)	2002-06-13
CA2437081C (en)	2010-10-19
DE60132801T2 (de)	2009-02-12
MXPA03005128A (es)	2004-12-06
CY1111322T1 (el)	2015-08-05
DE60132801D1 (de)	2008-03-27
EP1339837B1 (de)	2008-02-13
BR0116036A (pt)	2004-02-17
DE60142704D1 (en)	2010-09-09
DK1383393T3 (da)	2010-10-11
KR100867059B1 (ko)	2008-11-04
EP1339837A2 (de)	2003-09-03
NZ526271A (en)	2005-02-25
MXPA03005127A (es)	2004-10-15
WO2002045524A3 (en)	2002-10-24
PT1383393E (pt)	2010-09-16
US7608697B2 (en)	2009-10-27
US7309595B2 (en)	2007-12-18
CA2430893A1 (en)	2002-06-13
JP4991897B2 (ja)	2012-08-01
CN1484497A (zh)	2004-03-24
EP1383393A2 (de)	2004-01-28
DK1339837T3 (da)	2008-06-09
US20040241664A1 (en)	2004-12-02
JP2010213703A (ja)	2010-09-30
US20100112635A1 (en)	2010-05-06
KR20030085112A (ko)	2003-11-03
KR20030066694A (ko)	2003-08-09
ES2301579T3 (es)	2008-07-01
CA2430893C (en)	2013-07-30
KR20080108630A (ko)	2008-12-15

Publication	Publication Date	Title
ES2347320T3 (es)	2010-10-28	Hidrolizados proteicos enriquecidos en peptidos que tienen un resto de prolina carboxi terminal.
AU2002234561A1 (en)	2002-08-22	Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
EP2283129B1 (de)	2017-01-25	Prolin-spezifische protease aus penicillium chrysogenum
JP2009540847A (ja)	2009-11-26	ペプチジルアルギニンデイミナーゼ、およびシトルリン化タンパク質およびペプチド生成におけるその使用
CN101479380A (zh)	2009-07-08	肽酰精氨酸脱亚胺酶及其在生产瓜氨酸化的蛋白和肽中的用途
AU2002216089B2 (en)	2007-03-08	Prolyl endoprotease from aspergillus niger
CN100497616C (zh)	2009-06-10	富含具有羧基末端脯氨酸残基的肽的蛋白质水解产物
AU2002216089A1 (en)	2002-08-22	Prolyl endoprotease from aspergillus niger